We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Reports Positive Results From Phase 1 Trial of its COVID-19 Vaccine Candidate
Novavax Reports Positive Results From Phase 1 Trial of its COVID-19 Vaccine Candidate
Novavax has announced preliminary data from a phase 1 trial of its COVID-19 vaccine NVX-CoV2373 in Australia that showed the vaccine generated a strong immune response.